Biden starts new offensive to bring down medicine prices
Novo and Lundbeck are dropping on the stock exchange as it is revealed that US President Joe Biden wants an extensive plan to fight high prices on prescription medicine in place within the next 45 days.
BY RITZAU FINANS, TRANSLATED BY CATHERINE BRETT
US President Joe Biden issued an order on Friday criticizing the high prices of prescription medicine in the US, which according to the president are more than 2.5 times higher than in other countries - if not more.
In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.
The US retail chain has stopped selling its own private label hearing aids – and until the next generation comes along, other hearing companies selling products via Costco are enjoying the empty shelf space.